BridgeBio Pharma Comprehensive Income 2018-2024 | BBIO
BridgeBio Pharma comprehensive income from 2018 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.